Status:
RECRUITING
REVIVe: Frailty, Rehabilitation, and Outcomes in Critically Ill Adult and Pediatric Survivors of COVID-19 or ARI
Lead Sponsor:
McMaster University
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
Canadian Critical Care Trials Group
Conditions:
Respiratory Disease
COVID-19
Eligibility:
All Genders
Brief Summary
Background: Many adults and some children with COVID-19 or acute respiratory infection become critically ill and need advanced life support in the Intensive Care Unit (ICU). Frailty is a medical condi...
Eligibility Criteria
Inclusion
- Adult and pediatric survivors of COVID-19 or acute respiratory infection admitted to participating intensive care units (ICUs) and PICUs. The investigators define children as less than, and adults as greater than or equal to, 18 years old, respectively. The investigators will include adults and pediatrics with a confirmed diagnosis of COVID-19, pediatric patients with MIS-C, and adults and pediatrics with suspected or proven acute respiratory infection with onset within 14 days of ICU/PICU admission and requiring invasive mechanical ventilation, non-invasive ventilation, or high flow oxygen therapy.
Exclusion
- Patients who were admitted to ICU for \<24 hours
Key Trial Info
Start Date :
August 24 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
900 Patients enrolled
Trial Details
Trial ID
NCT05246098
Start Date
August 24 2022
End Date
October 1 2025
Last Update
November 6 2024
Active Locations (28)
Enter a location and click search to find clinical trials sorted by distance.
1
Alberta Children's Hospital
Calgary, Alberta, Canada, T3B 6A8
2
University of Alberta
Edmonton, Alberta, Canada, T6G2B7
3
Sturgeon Community Hopsital
St. Albert, Alberta, Canada, T8N 6C4
4
Royal Columbian Hospital
New Westminster, British Columbia, Canada, V3L 0A4